Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-09 Purchase | 2025-09-11 9:03 pm | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Casdin Eli Director 10% Owner | 100,000 | $1.2892 | $128,920 | 80,459,918 (Indirect Direct) | View |
| 2025-09-03 Purchase | 2025-09-05 7:08 pm | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Casdin Eli Director 10% Owner | 500,000 | $1.2715 | $635,750 | 80,359,918 (Indirect Direct) | View |
| 2025-08-22 Purchase | 2025-08-26 8:46 pm | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Casdin Eli Director 10% Owner | 525,000 | $1.2549 | $658,798 | 79,859,918 (Indirect Direct) | View |
| 2025-08-13 Purchase | 2025-08-15 9:18 pm | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Eli Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director 10% Owner | 358,220 | $1.2368 | $443,033 | 79,334,918 (Indirect Direct) | View |
| 2025-05-23 Sale | 2025-05-28 5:54 pm | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 1,428 | $0.941 | $1,344 | 930,286 (Direct) | View |
| 2025-05-23 Sale | 2025-05-28 5:52 pm | STANDARD BIOTOOLS INC. | LAB | Mackay Sean SVP & Chief Business Officer | 13,217 | $0.941 | $12,437 | 843,076 (Direct) | View |
| 2025-05-23 Sale | 2025-05-28 5:44 pm | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 5,473 | $0.941 | $5,150 | 2,741,191 (Direct) | View |
| 2025-05-22 Sale | 2025-05-27 8:33 pm | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 1,355 | $1.002 | $1,358 | 931,714 (Direct) | View |
| 2025-05-22 Sale | 2025-05-27 8:28 pm | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 5,116 | $1.002 | $5,126 | 2,746,664 (Direct) | View |
| 2025-05-21 Sale | 2025-05-23 6:13 pm | STANDARD BIOTOOLS INC. | LAB | Mackay Sean SVP & Chief Business Officer | 25,374 | $1.0162 | $25,784 | 856,293 (Direct) | View |
| 2025-05-21 Sale | 2025-05-22 8:03 pm | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 4,719 | $1.03 | $4,861 | 2,751,780 (Direct) | View |
| 2025-05-21 Sale | 2025-05-22 8:01 pm | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 1,407 | $1.03 | $1,449 | 933,069 (Direct) | View |
| 2025-02-28 Purchase | 2025-03-04 8:19 pm | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Eli Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. Casdin Amplify Fund LP CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director 10% Owner | 4,820,959 | $1.065 | $5,134,321 | 20,580,326 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-20 Tax Withholding | 2025-08-22 5:46 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 54,919 | $1.27 | 5,681,366 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 5:45 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Mackay Sean SVP & Chief Business Officer | 19,661 | $1.27 | 799,496 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 5:45 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 12,739 | $1.27 | 2,427,825 (Direct) | View |
| 2025-08-01 Option Award | 2025-08-05 6:33 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 1,500,000 | $0 | 2,440,564 (Direct) | View |
| 2025-08-01 Option Award | 2025-08-05 6:23 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 3,000,000 | $0 | 5,736,285 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:00 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | Cox Troy Director | 220,252 | $0 | 382,072 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:58 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | ELOI FENEL M Director | 220,252 | $0 | 361,843 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:58 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | Carey Thomas D. Director | 283,082 | $0 | 382,548 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:57 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | Casdin Eli Director 10% Owner | 220,252 | $0 | 79,102,358 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:55 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | HIBBS KATHY L Director | 220,252 | $0 | 263,380 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:53 pm | N/A 2035-06-20 | STANDARD BIOTOOLS INC. | LAB | Witney Frank Director | 220,252 | $0 | 340,747 (Direct) | View |
| 2025-05-28 Tax Withholding | 2025-05-30 5:52 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Mackay Sean SVP & Chief Business Officer | 23,919 | $1.09 | 819,157 (Direct) | View |
| 2025-05-28 Tax Withholding | 2025-05-30 5:48 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 9,906 | $1.09 | 2,731,285 (Direct) | View |
| 2025-05-28 Tax Withholding | 2025-05-30 5:48 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 2,583 | $1.09 | 927,703 (Direct) | View |
| 2025-05-20 Tax Withholding | 2025-05-22 8:03 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 18,343 | $1.05 | 2,751,780 (Direct) | View |
| 2025-05-20 Tax Withholding | 2025-05-22 8:01 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 6,364 | $1.05 | 933,069 (Direct) | View |
| 2025-04-04 Exercise | 2025-04-08 4:04 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 196,512 | $0 | 2,971,355 (Direct) | View |
| 2025-04-04 Tax Withholding | 2025-04-08 4:04 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 57,676 | $1.07 | 2,971,355 (Direct) | View |
| 2025-04-04 Exercise | 2025-04-08 4:03 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 70,183 | $0 | 1,011,023 (Direct) | View |
| 2025-04-04 Tax Withholding | 2025-04-08 4:03 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 21,441 | $1.07 | 1,011,023 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-24 6:37 pm | N/A 2035-03-21 | STANDARD BIOTOOLS INC. | LAB | Kim Hanjoon Alex Chief Financial Officer | 845,833 | $0 | 1,399,598 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-24 6:37 pm | N/A 2035-03-21 | STANDARD BIOTOOLS INC. | LAB | Mackay Sean SVP & Chief Business Officer | 704,167 | $0 | 1,304,167 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-24 6:31 pm | N/A 2035-03-21 | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 2,970,833 | $0 | 4,418,506 (Direct) | View |
| 2025-02-28 Other | 2025-03-04 8:19 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Eli Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. Casdin Amplify Fund LP CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director 10% Owner | 545,000 | $1.065 | 20,580,326 (Indirect) | View |
| 2025-02-28 Option Award | 2025-03-04 8:19 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Casdin Partners Master Fund L.P. Casdin Eli Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Casdin Private Growth Equity Fund L.P. Casdin Amplify Fund LP CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director 10% Owner | 58,215 | $1.065 | 20,580,326 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 5:52 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Carey Thomas D. Director | 56,338 | $1.065 | 99,466 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 5:51 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Cox Troy Director | 62,910 | $1.065 | 224,730 (Direct) | View |
| 2025-02-20 Tax Withholding | 2025-02-24 5:30 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 31,031 | $1.39 | 1,447,673 (Direct) | View |
| 2024-11-20 Tax Withholding | 2024-11-21 8:55 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 28,795 | $1.51 | 1,473,704 (Direct) | View |
| 2024-08-20 Tax Withholding | 2024-09-05 6:00 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Black Jeffrey G. SVP & Chief Financial Officer | 6,690 | $1.91 | 421,608 (Direct) | View |
| 2024-08-20 Tax Withholding | 2024-09-05 5:59 pm | N/A N/A | STANDARD BIOTOOLS INC. | LAB | Egholm Michael President & CEO | 29,093 | $1.91 | 1,502,499 (Direct) | View |